Less than 30 days after receiving FDA De Novo marketing authorization, Distalmotion’s Dexter Surgical Robot has successfully treated the first US patients in an outpatient setting. Two adult inguinal hernia repairs were completed with Dexter on November 26.
Greg Roche, Distalmotion’s CEO, says: “With over 90 percent of inguinal hernia repairs in the US performed in outpatient and ambulatory surgical settings, there is a need for robotic solutions tailored to these environments.
“We are thrilled to demonstrate how Dexter can overcome the traditional barriers of cost, space, and workflow disruption in the outpatient setting, while delivering robotic excellence that elevates surgeon and patient care.” [Read more…] about Distalmotion surgical robot used for first time in outpatients department